Viewing Study NCT04387227


Ignite Creation Date: 2025-12-25 @ 5:08 AM
Ignite Modification Date: 2025-12-26 @ 4:12 AM
Study NCT ID: NCT04387227
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-09-18
First Post: 2020-05-06
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Pembrolizumab and Carboplatin for the Treatment of Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Sponsor: University of Washington
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module